Dr. Lal Pathlabs Limited — Call Transcript 2019

May 14, 2019

May 14, 2019

National Stock Exchange of India Limited Exchange Plaza, Plot No. C/1, G Block, Sandra Kurla Complex Sandra (E) Mumbai - 400 051.

BSE Limited Corporate Relationship Department Phiroze Jeejeebhoy Towers Dalal Street Mumbai- 400001

Dear Sir/Madam,

Sub: Intimation of Conference Call for Investors/Analysts for Q4 & FY 19.

Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015, please find attached the invite of the Conference Call for Investors/Analysts to be held on Friday, May 17, 2019 at 4:00 PM 1ST to discuss the financial and operating performance for 04 & FY19.

You are requested to take note of the above.

Thanking You,

Yours Faithfully,

For Dr. Lal PathLabs Limited

Rajat Kalra Company Secretary & Legal Head

Encl: As above

Conference Call Invitation

Dr. Lal PathLabs' Q4 & FY19 Concall Invitation

Q4 & FY19 Earnings Conference Call Friday, May 17, 2019 at 04:00 pm IST

Gurgaon, May 14, 2019:

Dr. Lal PathLabs Ltd. (DLPL) will be hosting a conference call to discuss its Q4 & FY19 results. DLPL will be represented by (Hony) Brig. Dr. Arvind Lal - Chairman and Managing Director, Dr. Om Prakash Manchanda - Whole-time Director and CEO, Mr. Ved Prakash Goel - CFO. We would also have Mr. Bharath U - CEO (India Business) and Mr. Rajat Kalra - Company Secretary & Head of Investor Relations.

The conference call will be initiated with a brief discussion by the management on the Q4 & FY19 financial and operating performance, which will be announced on the same day. Following this, there will be an opportunity for participants to get their queries addressed during the call.

Details of the conference call are as follows:

Time	 04:00 pm IST on Friday, May 17, 2019
Universal Access	 Primary – +91 22 6280 1141  Secondary – +91 22 7115 8042
Local Access	 +91-70456 71221 (Available all over India)
Conference dial-in International Toll Number	 USA – 18667462133
	 UK – 08081011573
	 Singapore – 8001012045
	 Hong Kong – 800964448
Replay	 +91 22 71945757 / +91 22 66635757  68124 (passcode)  Valid from May 17, 2019 to May 23, 2019
Pre-registration	To enable participants to connect to the conference call without having to wait for an operator, please register at the below mentioned link
	You will receive dial in numbers, passcode and a pin for the concall on the registered email address provided by you. Kindly dial into the call on the Conference Call date and use the passcode & pin to connect to call

-ENDS-

About Dr. Lal PathLabs Limited (DLPL)

Dr. Lal PathLabs Limited is one of India's leading consumer healthcare brand in diagnostic services. It has an integrated nationwide network, where patients and healthcare providers are offered a broad range of diagnostic and related healthcare tests and services for use in: core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. The services of DLPL are aimed at individual patients, hospitals and other healthcare providers and corporates.

As on March 31, 2018, DLPL has 193 clinical labs (including National Reference Lab at Delhi & Kolkata Reference Lab), 2,153 Patient Service Centers (PSCs) and 5,624 Pick-up Points (PUPs). In FY17 & FY18, DLPL collected and processed approximately 29.3 million samples and 34.7 million samples from approximately 13.3 million and 15.2 million patients, respectively.

Additional information on Dr. Lal PathLabs Limited: Corporate Identification No: L74899DL1995PLC065388 Website:https://www.lalpathlabs.com/

For further information please contact:

Ved Goel / Rajat Kalra Dr. Lal PathLabs Limited Tel: +91 124 301 6500 Fax: +91 124 423 4468 E-mail:ved.goel@lalpathlabs.com rajat.kalra@lalpathlabs.com

Siddharth Rangnekar / Nishid Solanki CDR India Tel: +91 22 66451209 / 1221 Fax: +91 22 66451213 Email: siddharth@cdr-india.com nishid@cdr-india.com